Eric H. Bjerkholt
2014 - Sunesis Pharmaceuticals
In 2014, Eric H. Bjerkholt earned a total compensation of $1.3M as Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $117,500 |
|---|---|
| Option Awards | $741,762 |
| Salary | $390,062 |
| Other | $4,306 |
| Total | $1,253,630 |
Bjerkholt received $741.8K in option awards, accounting for 59% of the total pay in 2014.
Bjerkholt also received $117.5K in non-equity incentive plan, $390.1K in salary and $4.3K in other compensation.
Rankings
In 2014, Eric H. Bjerkholt's compensation ranked 6,562nd out of 13,032 executives tracked by ExecPay. In other words, Bjerkholt earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,562 out of 13,032 | 50th |
Division Manufacturing | 2,394 out of 4,965 | 52nd |
Major group Chemicals And Allied Products | 806 out of 1,690 | 52nd |
Industry group Drugs | 629 out of 1,369 | 54th |
Industry Pharmaceutical Preparations | 480 out of 1,042 | 54th |
Source: SEC filing on April 20, 2017.
Bjerkholt's colleagues
We found one more compensation record of an executive who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2014.
2014
Daniel Swisher
Sunesis Pharmaceuticals